Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status

Fig. 3

Comparison of survival curves based on serum albumin levels. In the patients with serum albumin levels ≥3.40 g/dL, overall survival (OS) was significantly better in the chemotherapy group than that in the BSC group (a); in patients with serum albumin levels <3.40 g/dL, the OS did not differ between chemotherapy and BSC groups (b)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us